^

Health

A
A
A

PCR diagnostics in gynecology

 
, medical expert
Last reviewed: 07.07.2025
 
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

The polymerase chain reaction (PCR) method now makes it possible to identify various infectious agents located in the inflammation focus. The most modern of the molecular methods of DNA hybridization allows identifying the human papilloma virus by serotypes. Molecular studies now make it possible to determine so-called tumor markers in blood serum - abnormal antigens of cells affected by malignant changes. With their help, cancer is recognized at the earliest stages (using the antigen-antibody reaction), when treatment is most effective.

Types of tumor markers used in gynecological practice

Tumor markers

Detectable diseases

Carcinoembryonic antigen (CEA) Monitoring of rectal, stomach, breast and bronchial cancer
alpha-fetoprotein Pregnancy monitoring, diagnosis and monitoring of primary hepatocellular carcinoma and embryonic cell tumors
CA 15-3 Monitoring of breast cancer therapy (used in combination with CEA)
CA 125, CA 19-9 Monitoring ovarian cancer
CA 72-4 Gastric cancer, mucinous ovarian cancer
Human chorionic gonadotropin (beta-HCG) Non-seminomatous embryonal cell tumors, chorioepithelioma, hydatidiform mole
Mucin-like antigen Breast cancer

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.